Synapse Open Synapse
Patents & IP

China expands drug protection regime with rare-disease, paediatric medicine exclusivity framework

IAM ·

Draft implementing rules introduce market exclusivity periods of up to seven years for rare-disease drugs and up to two years for paediatric medicines

Latest from IAM